Analyst Activity – Cantor Fitzgerald Reiterates Hold on AMAG Pharmaceuticals (NASDAQ:AMAG)

ME Staff
-
0

Analyst Ratings For AMAG Pharmaceuticals (NASDAQ:AMAG)

Today, Cantor Fitzgerald reiterated its Hold rating on AMAG Pharmaceuticals (NASDAQ:AMAG).

There are 1 sell rating, 9 hold ratings, 2 buy ratings on the stock.

The current consensus rating on AMAG Pharmaceuticals (NASDAQ:AMAG) is Hold (Score: 2.08) with a consensus target price of $28.70 per share, a potential 44.58% upside.

Some recent analyst ratings include

  • 7/24/2017-Cantor Fitzgerald Reiterated Rating of Hold.
  • 6/1/2017-Barclays PLC Reiterated Rating of Equal Weight.
  • 5/3/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 2/3/2017-Cowen and Company was Downgraded by analysts at Cowen and Company from a “Outperform ” rating to a ” Market Perform” rating.


  • On 7/13/2017 Julie Krop, SVP, sold 4,938 with an average share price of $20.00 per share and the total transaction amounting to $98,760.00. View SEC Filing
  • On 5/1/2017 Julie Krop, SVP, sold 1,891 with an average share price of $24.45 per share and the total transaction amounting to $46,234.95. View SEC Filing
  • On 10/20/2016 Julie Krop, SVP, sold 4,938 with an average share price of $24.80 per share and the total transaction amounting to $122,462.40. View SEC Filing
  • On 11/10/2015 John A Fallon, Director, bought 3,230 with an average share price of $31.20 per share and the total transaction amounting to $100,776.00. View SEC Filing
  • On 10/1/2015 William K Heiden, CEO, sold 2,000 with an average share price of $39.69 per share and the total transaction amounting to $79,380.00. View SEC Filing
  • On 9/1/2015 William K Heiden, CEO, sold 2,000 with an average share price of $61.19 per share and the total transaction amounting to $122,380.00. View SEC Filing
  • On 7/15/2015 William K Heiden, CEO, sold 20,000 with an average share price of $75.00 per share and the total transaction amounting to $1,500,000.00. View SEC Filing

Recent Trading Activity for AMAG Pharmaceuticals (NASDAQ:AMAG)
Shares of AMAG Pharmaceuticals closed the previous trading session at 19.85 up +0.55 2.85% with 626,228 shares trading hands.